Clinical applications of LHRH and its analogues

Clinical Endocrinology, 18(6), 571-592

DOI 10.1111/j.1365-2265.1983.tb00595.x PMID 6136347

Abstract

The physiological requirement for activation of pituitary gonadotrophin secretion by pulsatile LHRH stimulation is discussed, and compared with the effect of pituitary stimulation by LHRH agonists. Initial stimulation is followed by a phase of progressive pituitary and gonadal inhibition. This inhibition is fully reversible at the end of agonist treatment. Clinical applications of high dose suppression are the treatment of precocious puberty and hormone-dependent tumours (mammary and prostatic carcinoma). In women, agonist administration by nasal spray is a reversible method of inhibiting ovulation, and may also be useful in the treatment of endometriosis. Clinical advantages of agonist therapy are favourable biological tolerance, lack of side effects and rapid reversibility.

Topics

LHRH agonist clinical applications pituitary suppression, GnRH analogues ovulation inhibition endometriosis treatment, LHRH agonist precocious puberty hormone-dependent tumours, Sandow LHRH analogues clinical endocrinology, pulsatile LHRH gonadotrophin secretion physiology, GnRH agonist nasal spray reversible contraception, LHRH agonist pituitary desensitization gonadal suppression, GnRH analogue prostatic mammary carcinoma treatment, LHRH agonist endometriosis medical therapy reversibility, gonadotropin releasing hormone agonist clinical review 1983
PMID 6136347 6136347 DOI 10.1111/j.1365-2265.1983.tb00595.x 10.1111/j.1365-2265.1983.tb00595.x

Cite this article

Sandow, J. (1983). Clinical applications of LHRH and its analogues. *Clinical endocrinology*, *18*(6), 571-592. https://doi.org/10.1111/j.1365-2265.1983.tb00595.x

Related articles